Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $23,255 | 1,270 | 98.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $320.00 | 5 | 1.4% |
| Education | $100.75 | 6 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,849 | 163 | $0 (2024) |
| ABBVIE INC. | $2,304 | 113 | $0 (2024) |
| Novo Nordisk Inc | $2,202 | 136 | $0 (2024) |
| PFIZER INC. | $1,805 | 94 | $0 (2024) |
| Lilly USA, LLC | $1,544 | 99 | $0 (2024) |
| Amgen Inc. | $1,454 | 63 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,452 | 82 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,388 | 70 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $942.22 | 50 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $785.91 | 58 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,907 | 140 | ABBVIE INC. ($512.66) |
| 2023 | $3,109 | 156 | AbbVie Inc. ($712.93) |
| 2022 | $2,781 | 154 | ABBVIE INC. ($418.28) |
| 2021 | $3,273 | 177 | AbbVie Inc. ($609.55) |
| 2020 | $3,443 | 196 | AstraZeneca Pharmaceuticals LP ($877.16) |
| 2019 | $2,893 | 154 | AstraZeneca Pharmaceuticals LP ($815.98) |
| 2018 | $2,784 | 152 | PFIZER INC. ($564.28) |
| 2017 | $2,486 | 152 | Merck Sharp & Dohme Corporation ($325.46) |
All Payment Transactions
1,281 individual payment records from CMS Open Payments — Page 1 of 52
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: Diabetes | ||||||
| 12/20/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $22.19 | General |
| Category: Respiratory | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Inflammation | ||||||
| 12/17/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $29.97 | General |
| Category: PAIN | ||||||
| 12/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $8.36 | General |
| Category: Cardio-renal | ||||||
| 12/09/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $109.75 | General |
| Category: Bone Health | ||||||
| 11/26/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Biological | ||||||
| 11/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Cardio-renal | ||||||
| 11/20/2024 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: Gastroenterology | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $20.68 | General |
| 11/13/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: Inflammation | ||||||
| 11/08/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/05/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: RESPIRATORY | ||||||
| 10/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: Obesity | ||||||
| 10/21/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: Gastroenterology | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,804 | 2,081 | $340,380 | $189,999 |
| 2022 | 21 | 1,630 | 2,748 | $294,296 | $191,211 |
| 2021 | 22 | 1,622 | 3,023 | $249,669 | $182,745 |
| 2020 | 22 | 1,841 | 3,363 | $233,805 | $161,301 |
All Medicare Procedures & Services
82 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 454 | 454 | $124,850 | $67,637 | 54.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 363 | 490 | $98,000 | $50,967 | 52.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 186 | 245 | $42,875 | $17,501 | 40.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 177 | 177 | $15,930 | $12,732 | 79.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 41 | 41 | $12,300 | $11,555 | 93.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 224 | 225 | $9,000 | $8,096 | 90.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 31 | 31 | $6,975 | $5,924 | 84.9% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 17 | 18 | $5,040 | $3,905 | 77.5% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 18 | 18 | $3,600 | $2,822 | 78.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 12 | 12 | $3,000 | $2,288 | 76.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $3,000 | $1,705 | 56.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 45 | 45 | $1,800 | $1,619 | 90.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 53 | 102 | $3,570 | $1,193 | 33.4% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 49 | 49 | $4,165 | $1,073 | 25.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 73 | 74 | $5,550 | $740.88 | 13.3% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 17 | 19 | $380.00 | $167.16 | 44.0% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 32 | 69 | $345.00 | $74.18 | 21.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 394 | 394 | $71,895 | $60,957 | 84.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 353 | 496 | $92,600 | $50,778 | 54.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 171 | 243 | $39,325 | $17,320 | 44.0% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 11 | 840 | $25,200 | $14,343 | 56.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 36 | 36 | $7,750 | $7,171 | 92.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 171 | 171 | $6,840 | $6,035 | 88.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 87 | 87 | $7,830 | $5,963 | 76.2% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2022 | 74 | 74 | $6,290 | $5,072 | 80.6% |
About Dr. Nicole Arcentales, D.O
Dr. Nicole Arcentales, D.O is a Internal Medicine healthcare provider based in Staten Island, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/01/2008. The National Provider Identifier (NPI) number assigned to this provider is 1538314703.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nicole Arcentales, D.O has received a total of $23,676 in payments from pharmaceutical and medical device companies, with $2,907 received in 2024. These payments were reported across 1,281 transactions from 57 companies. The most common payment nature is "Food and Beverage" ($23,255).
As a Medicare-enrolled provider, Arcentales has provided services to 6,897 Medicare beneficiaries, totaling 11,215 services with total Medicare billing of $725,256. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Staten Island, NY
- Active Since 12/01/2008
- Last Updated 07/08/2010
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1538314703
Products in Payments
- FARXIGA (Drug) $2,711
- UBRELVY (Drug) $1,267
- Kerendia (Drug) $942.22
- TRULICITY (Drug) $858.09
- TRELEGY ELLIPTA (Drug) $790.63
- Ozempic (Drug) $732.54
- VRAYLAR (Drug) $723.82
- XIFAXAN (Drug) $642.55
- BREZTRI (Drug) $609.42
- JANUVIA (Drug) $568.38
- CHANTIX (Drug) $527.77
- Saxenda (Drug) $495.42
- QULIPTA (Drug) $494.82
- EVENITY (Biological) $468.24
- Aimovig (Biological) $444.91
- JARDIANCE (Drug) $423.75
- SYMBICORT (Drug) $395.33
- EUCRISA (Drug) $387.63
- Vascepa (Drug) $369.92
- NURTEC ODT (Drug) $354.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Staten Island
Dr. Seth Brum, M.d, M.D
Internal Medicine — Payments: $409,260
Dr. Maryann Lee, M.d, M.D
Internal Medicine — Payments: $115,406
Dr. Alexander Beylinson, D.o, D.O
Internal Medicine — Payments: $61,903
Dr. Miguel Tirado, M.d, M.D
Internal Medicine — Payments: $35,111
Dr. Alan Dunton, M.d, M.D
Internal Medicine — Payments: $34,946
Dr. John Zafaranloo, M.d, M.D
Internal Medicine — Payments: $29,178